US 12,290,701 B2
Head wearable light therapy device
Katya Sverdlov, New York, NY (US); Eugenia Steingold, New York, NY (US); and David Conroy, New York, NY (US)
Assigned to JelikaLite LLC, New York, NY (US)
Filed by JelikaLite LLC, New York, NY (US)
Filed on Jun. 20, 2023, as Appl. No. 18/212,153.
Application 18/212,153 is a continuation of application No. 17/769,708, previously published as PCT/US2020/055782, filed on Oct. 15, 2020.
Claims priority of provisional application 63/033,756, filed on Jun. 2, 2020.
Claims priority of provisional application 62/940,788, filed on Nov. 26, 2019.
Claims priority of provisional application 62/915,221, filed on Oct. 15, 2019.
Prior Publication US 2024/0325779 A1, Oct. 3, 2024
Int. Cl. A61N 5/06 (2006.01); A61B 5/372 (2021.01)
CPC A61N 5/0622 (2013.01) [A61B 5/372 (2021.01); A61N 2005/0626 (2013.01); A61N 2005/0628 (2013.01); A61N 2005/0647 (2013.01); A61N 2005/0652 (2013.01); A61N 2005/0659 (2013.01); A61N 2005/0663 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A photobiomodulation neuro-therapy device comprising:
a portable head mounted device that is sized to be positioned on a patient's head, the portable head mounted device including a plurality of light emitting devices, a memory and a battery providing power to the portable head mounted device, each of the light emitting devices being operable in response to control signals to control emission of transcranial illuminating light into the patient having a near infrared wavelength delivered during a therapeutic period;
a processor mounted on the portable head mounted device, the processor being connected to each of the light emitting devices to execute instructions to communicate the control signals that individually control emission of illuminating light from each of the light emitting devices during the therapeutic period;
a sensor that measures a physiologic response of the patient, the sensor including an electroencephalogram (EEG) electrode device that measures a brain wave signal of the patient wherein the EEG electrode device communicates measured EEG signals to at least one of the processor mounted on the portable head mounted device and an external communication device; and
a wireless receiver mounted on the portable head mounted device that receives wireless signals from the external communication device programmed to transmit therapeutic parameters to the processor mounted on the portable head mounted device.